R&D
Safeguarding the pharmaceutical supply chain
As we hear of the volcanic and seismic activity taking place in …
20621 items found
News
First drug backed for NHS use in untreated Hodgkin lymphoma
Takeda's Adcetris has become the first drug recommended for routine …
News
Third time not so lucky in J&J's bid to end talc liability
Johnson & Johnson's third attempt to use bankruptcy proceedings to …
News
Study links 'bad cholesterol' to dementia
Reducing levels of LDL-cholesterol can reduce the risk of dementia by …
News
Pharma tariffs "will hurt US consumers most of all"
With the world braced for an announcement of sweeping tariffs later …
News
Death penalty sought for suspect in UnitedHealth CEO killing
Prosecutors in the US are seeking the death penalty for Luigi …
Digital
Sponsored
Enabling Digitally Enhanced Care for Rare Diseases in Europe
This pre-recorded webinar was fully funded by Chiesi GRD and hosted …
News
RIF job losses are underway at HHS agencies; reports
Reduction in force (RIF) job losses have started in earnest at US …
News
UK first to approve Rotop's prostate cancer imaging agent
The Medicines and Healthcare products Regulatory Agency (MHRA) in the …
News
EVERSANA joins with Veeva in push to 'pharmatise AI'
Commercial services player EVERSANA has joined the growing number of …
News
ACC25: AZ stakes its claim to the oral PCSK9 category
AstraZeneca has revealed phase 2b results with its oral PCSK9 …
News
ACC25: Mineralys' uncontrolled hypertension drug aces trial
What can you do if a patient with hypertension can't control their …
News
First drug backed for NHS use in untreated Hodgkin lymphoma
Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated late-stage Hodgkin lymphoma.
Digital
Sponsored
Enabling Digitally Enhanced Care for Rare Diseases in Europe
Integrating AI and Connected Care Technologies in Lysosomal Storage Disease Patient Journeys
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Part 7
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Life Sciences Industry Report - Part 5
Developments in the oncology space in 2024 brought hope to both industry and patients.
R&D
ISPE Singapore Affiliate Conference & Exhibition 2025
The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals.
R&D
Partner Content
Return to Europe for the 2nd IMPACCT Real World Evidence Sum...
The IMPACCT Real World Evidence Summit is back, offering the opportunity to bring together 50+ pharma RWE decision makers to discuss integrated evidence plans, data sharing optimization, infrastruc
